this article talks about 3 health care companies that could help your money grow. these companies are oversold, which means they are undervalued and might increase in price soon. the article suggests that these 3 companies are good to invest in: agilon health, verrica pharmaceuticals, and alx oncology holdings. investing in these companies could make your money grow faster. Read from source...

The top 3 health care stocks that could rescue your portfolio this month feature Agilon Health Inc, Verrica Pharmaceuticals Inc, and ALX Oncology Holdings Inc. However, these oversold stocks could also signal a potential rebound or bottoming out point. To evaluate these possibilities, it is essential to examine their recent financial performance and news updates. Agilon Health reported worse- than-expected second-quarter revenue results and issued FY24 revenue guidance below estimates, but its stock fell around 37% over the past month. Verrica Pharmaceuticals reported better-than-expected second-quarter financial results and released preliminary results from Part 2 of its Phase 2 trial of VP-315 for basal cell carcinoma, yet its stock fell around 64% over the past month. ALX Oncology posted a narrower-than-expected quarterly loss, and its shares fell around 56% over the past month. Although these oversold stocks indicate an opportunity to buy into undervalued companies, investors should conduct their own due diligence before making any investment decisions.

Neutral

Although the article discusses oversold health care stocks, the sentiment of the piece remains neutral. It provides information on a few specific stocks, but doesn't express a bullish or bearish opinion on them. It also doesn't offer any advice or recommendations for investors, nor does it express any personal views or opinions.

Based on the article `Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month`, I would like to recommend three potential investment options in the health care sector.

1. Agilon Health Inc (AGL) - Though AGL recently reported worse-than-expected second-quarter revenue results and issued FY24 revenue guidance below estimates, its stock is oversold with an RSI value of 27.10. The company's shares fell around 37% over the past month and has a 52-week low of $4.38. Investors could consider buying the dip, but they should be aware of the risk that the company's guidance could further decrease.

2. Verrica Pharmaceuticals Inc (VRCA) - Verrica Pharmaceuticals recently reported better-than-expected second-quarter financial results. The company's stock fell around 64% over the past month and has a 52-week low of $2.53. With its RSI value of 19.52, VRCA is highly oversold. However, investors should note that despite the promising financial results, there could still be risks in investing in VRCA due to the volatile nature of its stock price.

3. ALX Oncology Holdings Inc (ALXO) - ALX Oncology posted a narrower-than-expected quarterly loss, which could be attractive to investors. However, the company's shares fell around 56% over the past month and has a 52-week low of $2.30, indicating it is also oversold with an RSI value of 28.48. Investors should be aware that the company is still in its early stages of development, and its future profitability is uncertain. As a result, investing in ALXO involves significant risk.

In conclusion, all three of these companies are oversold, and investors might consider buying into their undervalued stocks. However, it is crucial to note the significant risks involved in investing in these highly volatile healthcare stocks. Investors should do further research and consider seeking professional financial advice before making any investment decisions.